TGF-β activates both SMAD-independent and SMAD-dependent pathways that synergize with YAP/TAZ to initiate tumor progression (Hussain et al., 2025[53], Miranda et al., 2017[96]). The gene discussed is TGFB1; the disease is neoplasm.